NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1548222425 MD
Verify on CMS → Martha Grandits, MD
Rheumatology Physician in Saint Paul, Minnesota.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 504 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.6/100
▼ 1 pts below national avg 83.5 · Above neutral
Industry payments
$42.63
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Martha Grandits, MD reported a CMS MIPS final score of 82.6/100 - below the 83.5 national average - and filed 3,665 Medicare Part D claims in 2024.
- 82.6/100
- MIPS score · -1 vs avg
- 4K
- Part D claims, 2024
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Martha Grandits, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1548222425), first enumerated 04/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,665 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 82.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$42.63 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1548222425 · Rheumatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1548222425
- ENUM-LEGACY 2006
- TAX-MID 6K Rheumatology Physician
- MIPS-INLINE 82.6/100
- RX-MID 3,665
- BOOK-THIN 126 in Minnesota
- PHOTO-FINISH Sahdev Saharan · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Grandits · this …
Grandits · this provider
82.6 MIPS pts
- Rovinder Saini ·…
Rovinder Saini
82.6 MIPS pts
- Joseph Devich · …
Joseph Devich
82.6 MIPS pts
- Betsy Shook · near
Betsy Shook
82.6 MIPS pts
- Sahdev Saharan ·…
Sahdev Saharan
82.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Martha Grandits, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
83 ≥ 36th percentile 36% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Martha Grandits, MD sits
This provider among rheumatology physician peers
Across the 1,970 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Martha Grandits, MD writes more Part D claims than 82% of them and scores higher on MIPS quality than 38% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Martha Grandits, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Martha Grandits, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Martha Grandits, MD?
Near national averagePrimary specialty
Rheumatology Physician
Medicare Part D claims
3,665 78% vs specialty avg
MIPS final score
82.6/100 0.9 pts vs avg
Specialty distribution in Minnesota
How Rheumatology Physician compares to other specialties among Minnesota providers
Medicare quality performance, MIPS
Martha Grandits, MD's 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 82.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1548222425 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
82.6431
Final Score
Measured-score avg: 83.5
88.2148
Quality
51.1439
Cost
99
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Martha Grandits, MD. Source: openpaymentsdata.cms.gov.
Total received
$43
Largest payer
Mallinckrodt Hospital Products Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Martha Grandits, MD - brand share 13.0%
Rheumatology Physician average
13% brand-name claims vs 87% generic, on 3,665 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,665
Total Claims
$2.2M
Total Drug Cost
504
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,536.3
- Total Day Supply
- 189,529
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $83K
- Opioid Claims
- 427 (11.7% rate)
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.44
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 84, 65-74: 250, 75-84: 141, 85+: 29
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Martha Grandits, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Methotrexate
Methotrexate
438 claims
- Prednisone
Prednisone
369 claims
- Gabapentin
Gabapentin
332 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
301 claims
- Tramadol Hcl
Tramadol Hcl
272 claims
- Leflunomide 109
Leflunomide
109 claims
- Pregabalin 83
Pregabalin
83 claims
- Fluticasone Propio… 78
Fluticasone Propionate
78 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 438 |
| Prednisone | 369 |
| Gabapentin | 332 |
| Hydroxychloroquine Sulfate | 301 |
| Tramadol Hcl | 272 |
| Leflunomide | 109 |
| Pregabalin | 83 |
| Fluticasone Propionate | 78 |
| Cyclobenzaprine Hcl | 68 |
| Enbrel Sureclick Etanercept | 67 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Martha Grandits, MD fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Martha Grandits, MD's 3,665 claims are above the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Grandits, both outside Minnesota so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (82.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Minnesota
Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as Grandits.
One of 126 Rheumatology Physician providers enrolled in Minnesota, 5 are shown here.
Upasana Agrawal
MBBS
Rochester, MN
Dr. Fatima Alnaimat
M.D
Duluth, MN
Dr. Sara Baig
MD
Edina, MN
Dr. Hammad Bajwa
M.D.
Edina, MN
Dr. Gary Baker
MD
Saint Paul, MN
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Martha Grandits, MD's specialty? ▼
Martha Grandits, MD specializes in Rheumatology Physician and practices in Saint Paul, Minnesota. Credentials: MD.
How much does Martha Grandits, MD prescribe under Medicare Part D? ▼
In 2024, Martha Grandits, MD wrote 3,665 Medicare Part D claims totaling $2.2M in drug costs for 504 beneficiaries.
What is Martha Grandits, MD's Medicare quality score? ▼
Martha Grandits, MD has a CMS MIPS Final Score of 82.6/100 (Quality: 88.2, Cost: 51.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Martha Grandits, MD located? ▼
Martha Grandits, MD is located at 255 SMITH AVE N, Saint Paul, MN, 55102. Phone: (651) 241-5000.
What is Martha Grandits, MD's NPI number? ▼
Martha Grandits, MD's National Provider Identifier (NPI) is 1548222425, issued on 04/05/2006.
Does Martha Grandits, MD prescribe more brand-name or generic drugs? ▼
Martha Grandits, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $2.1M in brand drug costs.
Does Martha Grandits, MD prescribe opioids? ▼
Yes, Martha Grandits, MD had 427 opioid claims in 2024 with an opioid prescribing rate of 11.7%.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Martha Grandits, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Martha Grandits, MD's most frequently prescribed drugs include Methotrexate, Prednisone, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Martha Grandits, MD accept Medicare? ▼
Martha Grandits, MD appears in CMS Medicare data with 3,665 Part D claims and 504 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Martha Grandits, MD's credentials? ▼
Martha Grandits, MD's NPI is 1548222425 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.